NATUS MEDICAL INC
Healthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | |
|---|---|---|---|---|---|---|
| Revenue | $473.4M | $415.7M | $495.2M | $530.9M | $501.0M | $381.9M |
| Operating income | $23.8M | −$20.2M | −$15.7M | −$24.6M | $8.7M | $55.3M |
| Net income | $13.2M | −$16.6M | −$15.7M | −$22.9M | −$20.3M | $42.6M |
| Total assets | $564.3M | $600.4M | $622.5M | $638.1M | $709.9M | $649.0M |
| Total liabilities | $139.5M | $189.3M | $206.4M | $239.7M | $287.8M | $231.6M |
| Equity | $424.8M | $411.1M | $416.1M | $398.4M | $422.1M | $417.4M |
| EPS (diluted) | $0.39 | $-0.49 | $-0.47 | $-0.69 | $-0.62 | $1.29 |
| Shares out. | 33.9M | 34.1M | 33.8M | 33.2M | 32.9M | 33.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2021- Operating margin
- 5.0%
- Net margin
- 2.8%
- Return on equity
- 3.1%
- Return on assets
- 2.3%
- Return on capital (ROCE)
- 5.3%
- Liabilities / assets
- 24.7%
- Debt / equity
- 0.33×
- Book value / share
- $12.54
- Revenue growth (YoY)
- 13.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2021- Altman Z″ (distress)
- 5.86safe
- Accruals / assets
- −9.0%clean
- Piotroski F-Score
- 9/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 6 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 3, 2015
- NT 10-Qmissed a reporting deadline ↗May 13, 2013
- NT 10-Kmissed a reporting deadline ↗Mar 18, 2013
- NT 10-Qmissed a reporting deadline ↗May 11, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventJul 21, 2022
- Shareholder voteJul 7, 2022
- Shareholder voteJun 15, 2022
- Results of operationsMay 5, 2022
- Entered a material agreement · Director / officer change · Other material eventApr 18, 2022
- Results of operations · Director / officer changeFeb 24, 2022
- Results of operationsJan 10, 2022
- Director / officer changeDec 17, 2021
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.